Genetron (GTH) Short Interest Ratio & Short Volume → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free GTH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisHeadlinesOwnershipShort InterestSocial MediaStock AnalysisHeadlinesOwnershipShort InterestSocial Media Genetron Short Interest DataCurrent Short Volume20,800 sharesPrevious Short Volume10,600 sharesChange Vs. Previous Month+96.23%Dollar Volume Sold Short$81,120.00Short Interest Ratio / Days to Cover0.5Last Record DateMarch 15, 2024Outstanding Shares31,620,000 sharesFloat Size27,660,000 sharesShort Percent of Float0.08%Today's Trading Volume412,600 sharesAverage Trading Volume51,662 sharesToday's Volume Vs. Average799% Short Selling Genetron ? Sign up to receive the latest short interest report for Genetron and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGTH Short Interest Over TimeGTH Days to Cover Over TimeGTH Percentage of Float Shorted Over Time Ad Timothy SykesBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…>>Click here to discover why Bill Gates is all about this tiny $2 stock. Genetron Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202420,800 shares $81,120.00 +96.2%0.1%0.5 $3.90 2/29/202410,600 shares $41,552.00 -6.2%0.0%0.3 $3.92 2/15/202411,300 shares $42,940.00 +73.9%0.0%0.3 $3.80 1/31/20246,500 shares $24,570.00 +58.5%0.0%0.2 $3.78 1/15/20244,100 shares $15,170.00 -81.5%0.0%0.1 $3.70 12/31/202322,100 shares $81,328.00 +123.2%0.1%0.4 $3.68 Get the Latest News and Ratings for GTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter. 12/15/20239,900 shares $36,531.00 -36.1%0.0%0.2 $3.69 11/30/202315,500 shares $56,885.00 +80.2%0.1%0.4 $3.67 11/15/20238,600 shares $31,734.00 -49.4%0.0%0.2 $3.69 10/31/202317,000 shares $58,820.00 -87.8%0.1%0.4 $3.46 10/15/2023139,600 shares $166,124.00 -19.8%0.5%1.3 $1.19 9/30/2023174,000 shares $141,305.40 +6.9%0.2%3.1 $0.81 9/15/2023162,800 shares $133,496.00 +13.0%0.2%2.8 $0.82 8/31/2023144,100 shares $137,298.48 +9.8%0.2%2.5 $0.95 8/15/2023131,300 shares $120,796.00 +41.6%0.2%2.3 $0.92 7/31/202392,700 shares $86,071.95 -17.5%0.1%1.8 $0.93 7/15/2023112,400 shares $100,036.00 +8.8%0.1%2.6 $0.89 6/30/2023103,300 shares $96,079.33 +9.3%0.1%3.1 $0.93 6/15/202394,500 shares $87,875.55 -19.9%0.1%3.2 $0.93 5/31/2023118,000 shares $106,200.00 -25.6%0.1%4.9 $0.90 5/15/2023158,600 shares $149,068.14 -8.3%0.2%5.6 $0.94 4/30/2023172,900 shares $164,272.29 -1.5%0.2%4.7 $0.95 4/15/2023175,600 shares $158,040.00 -8.8%0.2%3.2 $0.90 3/31/2023192,500 shares $202,125.00 +41.7%0.2%2.5 $1.05 3/15/2023135,900 shares $124,212.60 -30.8%0.2%1.4 $0.91 2/28/2023196,400 shares $196,400.00 -25.2%0.2%1.6 $1.00 2/15/2023262,500 shares $279,562.50 +56.6%0.3%2 $1.07 1/31/2023167,600 shares $196,092.00 -41.7%0.2%1.1 $1.17 1/15/2023287,700 shares $339,486.00 -24.5%0.4%1.8 $1.18 12/30/2022380,800 shares $426,496.00 -19.8%0.5%2.6 $1.12 12/15/2022474,700 shares $507,929.00 +2.2%0.6%3.1 $1.07 11/30/2022464,700 shares $473,994.00 -16.2%0.6%2.5 $1.02 11/15/2022554,400 shares $531,336.96 +50.9%0.7%2.7 $0.96 10/31/2022367,500 shares $299,512.50 -8.0%0.5%1.5 $0.82 10/15/2022399,600 shares $321,717.96 +25.3%0.5%1.6 $0.81 9/30/2022319,000 shares $249,394.20 -29.6%0.4%1 $0.78 9/15/2022453,100 shares $475,755.00 +19.3%0.6%1.5 $1.05 8/31/2022379,800 shares $440,568.00 +66.7%0.5%1.4 $1.16 8/15/2022227,900 shares $243,853.00 -77.4%0.3%0.9 $1.07 7/31/20221,010,000 shares $1.08 million -4.7%1.2%4.3 $1.07Bill Gates is all about this tiny $2 stock (Ad)What does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…>>Click here to discover why Bill Gates is all about this tiny $2 stock. GTH Short Interest - Frequently Asked Questions What is Genetron's current short interest? Short interest is the volume of Genetron shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 20,800 shares of GTH short. 0.08% of Genetron's shares are currently sold short. Learn More on Genetron's current short interest. What is a good short interest percentage for Genetron? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Genetron's floating shares are currently sold short. Is Genetron's short interest increasing or decreasing? Genetron saw a increase in short interest in March. As of March 15th, there was short interest totaling 20,800 shares, an increase of 96.2% from the previous total of 10,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Genetron's float size? Genetron currently has issued a total of 31,620,000 shares. Some of Genetron's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genetron currently has a public float of 27,660,000 shares. How does Genetron's short interest compare to its competitors? 0.08% of Genetron's shares are currently sold short. Here is how the short interest of companies compare to Genetron: Amylyx Pharmaceuticals, Inc. (18.07%), OptiNose, Inc. (5.24%), Context Therapeutics Inc. (0.05%), Karyopharm Therapeutics Inc. (14.59%), So-Young International Inc. (0.04%), Molecular Partners AG (0.15%), aTyr Pharma, Inc. (0.92%), BioAtla, Inc. (11.08%), PDS Biotechnology Co. (18.70%), Omega Therapeutics, Inc. (22.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Genetron stock? Short selling GTH is an investing strategy that aims to generate trading profit from Genetron as its price is falling. GTH shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genetron? A short squeeze for Genetron occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GTH, which in turn drives the price of the stock up even further. How often is Genetron's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTH, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Amylyx Pharmaceuticals Short Interest OptiNose Short Interest Context Therapeutics Short Interest Karyopharm Therapeutics Short Interest So-Young International Short Interest Molecular Partners Short Interest aTyr Pharma Short Interest BioAtla Short Interest PDS Biotechnology Short Interest Omega Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GTH) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsUrgent Nvidia WarningAltimetryCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics41 banks launch ‘crypto dollar’Stansberry Research